Raymond James Financial
JAZZ icon

Raymond James Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Raymond James Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.6M Buy
184,464
+7,128
+4% +$1.25M 0.01% 1089
2025
Q4 		$30.2M Buy
177,336
+18,470
+12% +$2.83M 0.01% 1161
2025
Q3 		$20.9M Sell
158,866
-116
-0.1% -$13.9K 0.01% 1380
2025
Q2 		$16.9M Buy
158,982
+3,916
+3% +$425K 0.01% 1492
2025
Q1 		$19.3M Buy
155,066
+62,719
+68% +$8.18M 0.01% 1343
2024
Q4 		$11.4M Buy
+92,347
New +$10.9M ﹤0.01% 1743

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Raymond James Financial's JAZZ Position: Q1 2026 in Review

Raymond James Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 4% in Q1 2026, buying an estimated $1.25M and bringing the position to 184,464 shares worth $34.6M. The position accounts for 0.01% of the portfolio, ranked #1089.

Raymond James Financial first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Raymond James Financial held 184,464 shares of Jazz Pharmaceuticals worth $34.6M as of Q1 2026.
  • Raymond James Financial bought 7,128 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.25M.
  • Jazz Pharmaceuticals made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1089 holding.
  • Raymond James Financial first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.